Sodium Valproate: Compensation
The question
To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the potential impact of the absence of a (a) compensation and (b) redress scheme on the (i) long-term planning and (ii) care provision for families impacted by in utero exposure to sodium valproate.
Answered by Ashley Dalton
The Government is carefully considering the valuable work done by the Patient Safety Commissioner and the resulting Hughes Report, which set out options for redress for those harmed by valproate and pelvic mesh. This is a complex area of work, involving several Government departments, and it is important that we get this right. We will be providing an update to the Patient Safety Commissioner’s report at the earliest opportunity.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →